These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 34579753)
21. Predicting Prognosis and Distinguishing Cold and Hot Tumors in Bladder Urothelial Carcinoma Based on Necroptosis-Associated lncRNAs. Liu D; Xu S; Chang T; Ma S; Wang K; Sun G; Chen S; Xu Y; Zhang H Front Immunol; 2022; 13():916800. PubMed ID: 35860239 [TBL] [Abstract][Full Text] [Related]
22. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related]
23. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer. Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720 [TBL] [Abstract][Full Text] [Related]
24. TFRC, associated with hypoxia and immune, is a prognostic factor and potential therapeutic target for bladder cancer. Tang R; Wang H; Liu J; Song L; Hou H; Liu M; Wang J; Wang J Eur J Med Res; 2024 Feb; 29(1):112. PubMed ID: 38336764 [TBL] [Abstract][Full Text] [Related]
25. Uncovering the potential functions of lymph node metastasis-associated aberrant methylation differentially expressed genes and their association with the immune infiltration and prognosis in bladder urothelial carcinoma. Gao W; Zhang J; Tian T; Fu Z; Bai L; Yang Y; Wu Q; Wang W; Guo Y PeerJ; 2023; 11():e15284. PubMed ID: 37123010 [TBL] [Abstract][Full Text] [Related]
26. PVT1 is a prognostic marker associated with immune invasion of bladder urothelial carcinoma. Li P; Qiao G; Lu J; Ji W; Gao C; Qi F Math Biosci Eng; 2022 Jan; 19(1):169-190. PubMed ID: 34902986 [TBL] [Abstract][Full Text] [Related]
27. An EMT-related gene signature for the prognosis of human bladder cancer. Cao R; Yuan L; Ma B; Wang G; Qiu W; Tian Y J Cell Mol Med; 2020 Jan; 24(1):605-617. PubMed ID: 31657881 [TBL] [Abstract][Full Text] [Related]
28. PXDNL activates the motility of urothelial bladder carcinoma cells through the Wnt/β-catenin pathway and has a prognostic value. Lu M; Liu B; Li D; Gao Z; Li W; Zhou X; Zhan H Life Sci; 2023 Jan; 312():121270. PubMed ID: 36493879 [TBL] [Abstract][Full Text] [Related]
29. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer. Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P Front Oncol; 2023; 13():972558. PubMed ID: 37064115 [TBL] [Abstract][Full Text] [Related]
30. A novel survival model based on a Ferroptosis-related gene signature for predicting overall survival in bladder cancer. Liang Y; Ye F; Xu C; Zou L; Hu Y; Hu J; Jiang H BMC Cancer; 2021 Aug; 21(1):943. PubMed ID: 34418989 [TBL] [Abstract][Full Text] [Related]
31. Identification of five long noncoding RNAs signature and risk score for prognosis of bladder urothelial carcinoma. Zhang C; Li Z; Hu J; Qi F; Li X; Luo J J Cell Biochem; 2020 Jan; 121(1):856-866. PubMed ID: 31373406 [TBL] [Abstract][Full Text] [Related]
32. Construction and validation of a prognostic model for bladder cancer based on disulfidptosis-related lncRNAs. Yang X; Zhang Y; Liu J; Feng Y Medicine (Baltimore); 2024 Jul; 103(27):e38750. PubMed ID: 38968515 [TBL] [Abstract][Full Text] [Related]
33. A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma. Bao Z; Zhang W; Dong D Oncotarget; 2017 Feb; 8(6):10485-10497. PubMed ID: 28060759 [TBL] [Abstract][Full Text] [Related]
34. Tumor Expression Profile Analysis Developed and Validated a Prognostic Model Based on Immune-Related Genes in Bladder Cancer. Dong B; Liang J; Li D; Song W; Zhao S; Ma Y; Song J; Zhu M; Yang T Front Genet; 2021; 12():696912. PubMed ID: 34512722 [No Abstract] [Full Text] [Related]
35. Identification of stemness index-related long noncoding RNA SNHG12 in human bladder cancer based on WGCNA. Zhang B; He Y; Ma G; Zhang L; Qi P; Han D; Yue Z; Shang P Mol Cell Probes; 2022 Dec; 66():101867. PubMed ID: 36183925 [TBL] [Abstract][Full Text] [Related]
36. Development of a propionate metabolism-related gene-based molecular subtypes and scoring system for predicting prognosis in bladder cancer. Zheng F; Wang Z; Li S; Xiong S; Yuan Y; Zeng J; Tan Y; Liu X; Xu S; Fu B Eur J Med Res; 2024 Jul; 29(1):393. PubMed ID: 39075554 [TBL] [Abstract][Full Text] [Related]
37. Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer. Gao L; Meng J; Zhang M; Fan S; Gao S; Wang X; Liang C DNA Cell Biol; 2020 Jun; 39(6):1072-1089. PubMed ID: 32352838 [TBL] [Abstract][Full Text] [Related]
38. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes. Wang L; Wang Y; Wang J; Li L; Bi J J Immunol Res; 2021; 2021():3236384. PubMed ID: 34708131 [TBL] [Abstract][Full Text] [Related]
39. Identification of a basement membrane-related genes signature with immune correlation in bladder urothelial carcinoma and verification in vitro. Li Y; Xu K; Zhang Y; Mao H; Qiu Q; Yan Z; Liu X; Du Y; Chen Z BMC Cancer; 2023 Oct; 23(1):1021. PubMed ID: 37872487 [TBL] [Abstract][Full Text] [Related]